Suppr超能文献

桥接补片在巨大腹壁切口疝中的应用。

Application of bridging mesh repair in giant ventral incisional hernia.

机构信息

Department of Hernia and Abdominal Wall Surgery, Beijing Chaoyang Hospital, Capital Medical University, No. 8 Gongtinan Road, Chaoyang District, Beijing, 100020, China.

Department of Hernia and Abdominal Wall Surgery, Peking University People's Hospital, No.11 Xizhimennan Str., Xicheng District, Beijing, 100044, China.

出版信息

Updates Surg. 2024 Oct;76(6):2411-2420. doi: 10.1007/s13304-024-01825-3. Epub 2024 Mar 31.

Abstract

Achieving ideal abdominal wall reconstruction in giant ventral incisional hernia has been a challenging for surgeons. This study aimed to verify the safety and efficacy of bridging repair by comparing it with primary fascial closure (PFC) repair in the treatment of giant ventral incisional hernia. We retrospectively analyzed the clinical data of 92 patients with giant ventral incisional hernia who underwent mesh repair at our medical institution from January 1, 2014 to December 31, 2020. Patients were divided into 2 groups: the bridging repair group with 40 patients in whom repair was completed using the bridging technique and the PFC group with 52 patients in whom primary fascial closure was achieved and all patients underwent mesh reinforcement during the operation. The main outcome measures were recurrence rate and morbidity, especially intra-abdominal hypertension (IAH). Follow-up time of both groups lasted at least 24 months after surgery. After a median of 46 months and 65 months of follow-up, respectively, in the two groups, bridging repair did not increase the long-term recurrence rate (2.56%) in the larger defect area group compared to the PFC group (1.96%). There were no significant differences in perioperative morbidity, IAH, incidence of postoperative chronic pain, and sensory impairment of the abdominal wall between both groups. The application of bridging surgery in the treatment of complex giant ventral incisional hernias is safe and effective and does not significantly increase the postoperative recurrence rate.

摘要

实现巨大腹壁切口疝的理想腹壁重建一直是外科医生面临的挑战。本研究旨在通过比较桥接修复与原发性筋膜闭合(PFC)修复治疗巨大腹壁切口疝的安全性和有效性。我们回顾性分析了 2014 年 1 月 1 日至 2020 年 12 月 31 日在我院接受网片修复的 92 例巨大腹壁切口疝患者的临床资料。患者分为两组:桥接修复组 40 例,采用桥接技术完成修复;PFC 组 52 例,行原发性筋膜闭合术,所有患者在术中均行网片加强。主要观察指标为复发率和发病率,尤其是腹腔内高压(IAH)。两组患者的随访时间均至少为术后 24 个月。两组分别随访中位数 46 个月和 65 个月后,桥接修复在较大缺损面积组中并未增加长期复发率(2.56%),与 PFC 组(1.96%)相比差异无统计学意义。两组围手术期发病率、IAH、术后慢性疼痛发生率和腹壁感觉障碍发生率差异均无统计学意义。桥接手术在复杂巨大腹壁切口疝的治疗中是安全有效的,不会显著增加术后复发率。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验